Published :
Tables : 58
Figures : 42
Category : Healthcare
No. of Pages : 225
Report Code : HC-U3394
Continuous Positive Airway Pressure Devices Market is estimated to value over USD 4.1 billion by 2027 end with a CAGR of over 7.7% during the forecast period 2020 to 2027. Continuous positive airway pressure treatment is prominently used for treating obstructive sleep apnea using constant air pressure. These devices keep the airways open during sleep and it is used for controlling the output pressure by maintaining the airflow pressure. Furthermore, the rising occurrence of sleep disorders owing to a stressful lifestyle shall bolster the continuous positive airway pressure devices market growth. According to the CDC, over 340 million people across the world are diagnosed with sleep apnea. Such a growing awareness related to comorbid conditions like high blood pressure shall boost the market growth substantially. Continuous positive airways in nasal form is used on infants regularly and they are also recommended to be used every night. Some patients often complain about nasal and throat dryness, mask discomfort while using CPAD devices. Other users find it complicated to use especially while travelling. Such problems shall reduce the usage of these devices by patients leading to the impediment of the market growth. Continuous Positive Airway Pressure Devices Market Segmentation: By Product Manual CPAP Devices Automatic CPAP Devices By End User Hospitals Clinics Home Healthcare Centers By Region North America Europe Asia Pacific Latin America Middle East & Africa The market is categorized into type, end user and region. The type segment is fragmented into manual and automatic CPAP. The automatic devices segment is predicted to hold the largest continuous positive airway pressure devices (CPAP) market share, and this can be attribute to advancements in the hospital infrastructure and the rising adoption of automated CPAP devices across the world. The end user segment is diversified into clinics, hospitals and home healthcare centers. The hospital segment is anticipated to lead the market owing to rise in the number of hospitals across the world with an increasing patient population. Regional Analysis: The North America region is anticipated to lead the market owing to the strong presence of major market players in the region, growing investments in the research and development of CPAP devices, advancements in the hospital infrastructure. The Europe region is predicted to grow at a substantial rate during the forecast period and this can be credited to favorable regulatory guidelines coupled with an increased prevalence of sleep apnea in the region. Competitive Landscape: Some of the prominent players are ResMed, Philips Healthcare, Apria Healthcare, Apex Medical, Armstrong Medical, Bremed, BMC Medical, Cardinal Health, Dehaier Medical Systems, Curative Medical, DeVilbiss Healthcare, Genstar Technologies, Drager Medical, Hans Rudolph, Hersill, Heyer Medical, InnoMed Technologies, HOFFRICHTER GmbH, Intersurgical, Medtronic, Invacare, PAHSCO, Pneumocare, Penlon, Pulmodyne, Smiths Medical, Sleepnet, SOMNETICS, Sturdy Industrial, Weinmann Gerate fur Medizin. FutureWise Key Takeaways: Growth prospects SWOT analysis Key market trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global continuous positive airway pressure devices market by product, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Continuous positive airway pressure treatment is prominently used for treating obstructive sleep apnea using constant air pressure. These devices keep the airways open during sleep and it is used for controlling the output pressure by maintaining the airflow pressure. Furthermore, the rising occurrence of sleep disorders owing to a stressful lifestyle shall bolster the continuous positive airway pressure devices market growth. According to the CDC, over 340 million people across the world are diagnosed with sleep apnea. Such a growing awareness related to comorbid conditions like high blood pressure shall boost the market growth substantially. Continuous positive airways in nasal form is used on infants regularly and they are also recommended to be used every night. Some patients often complain about nasal and throat dryness, mask discomfort while using CPAD devices. Other users find it complicated to use especially while travelling. Such problems shall reduce the usage of these devices by patients leading to the impediment of the market growth.
Continuous Positive Airway Pressure Devices Market Segmentation:
By Product
By End User
By Region
The market is categorized into type, end user and region. The type segment is fragmented into manual and automatic CPAP. The automatic devices segment is predicted to hold the largest continuous positive airway pressure devices (CPAP) market share, and this can be attribute to advancements in the hospital infrastructure and the rising adoption of automated CPAP devices across the world. The end user segment is diversified into clinics, hospitals and home healthcare centers. The hospital segment is anticipated to lead the market owing to rise in the number of hospitals across the world with an increasing patient population.
Regional Analysis:
The North America region is anticipated to lead the market owing to the strong presence of major market players in the region, growing investments in the research and development of CPAP devices, advancements in the hospital infrastructure. The Europe region is predicted to grow at a substantial rate during the forecast period and this can be credited to favorable regulatory guidelines coupled with an increased prevalence of sleep apnea in the region.
Competitive Landscape:
Some of the prominent players are ResMed, Philips Healthcare, Apria Healthcare, Apex Medical, Armstrong Medical, Bremed, BMC Medical, Cardinal Health, Dehaier Medical Systems, Curative Medical, DeVilbiss Healthcare, Genstar Technologies, Drager Medical, Hans Rudolph, Hersill, Heyer Medical, InnoMed Technologies, HOFFRICHTER GmbH, Intersurgical, Medtronic, Invacare, PAHSCO, Pneumocare, Penlon, Pulmodyne, Smiths Medical, Sleepnet, SOMNETICS, Sturdy Industrial, Weinmann Gerate fur Medizin.
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Continuous Positive Airway Pressure Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Continuous Positive Airway Pressure Devices Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Continuous Positive Airway Pressure Devices Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Continuous Positive Airway Pressure Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Continuous Positive Airway Pressure Devices Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Manual CPAP Devices 7.2. Automatic CPAP Devices 8. Global Continuous Positive Airway Pressure Devices Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Hospitals 8.2. Clinics 8.3. Home Healthcare Centers 9. North America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Saudi Arabia 13.2.2. UAE 13.2.3. South Africa 13.2.4. Egypt 13.3. Market Size (USD Million) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 14.1. Resmed 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Philips Healthcare 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Apria Healthcare 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Apex Medical 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. Armstrong Medical 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6. Bremed 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. BMC Medical 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. Cardinal Health 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. Dehaier Medical Systems 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10. Curative Medical 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11. DeVilbiss Healthcare 14.11.1. Company Overview 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview 14.12. Genstar Technologies 14.12.1. Company Overview 14.12.2. Product Portfolio 14.12.3. SWOT Analysis 14.12.4. Financial Overview 14.12.5. Strategic Overview 14.13. Drager Medical 14.13.1. Company Overview 14.13.2. Product Portfolio 14.13.3. SWOT Analysis 14.13.4. Financial Overview 14.13.5. Strategic Overview 14.14. Hans Rudolph 14.14.1. Company Overview 14.14.2. Product Portfolio 14.14.3. SWOT Analysis 14.14.4. Financial Overview 14.14.5. Strategic Overview 14.15. Hersill 14.15.1. Company Overview 14.15.2. Product Portfolio 14.15.3. SWOT Analysis 14.15.4. Financial Overview 14.15.5. Strategic Overview 14.16. Heyer Medical 14.16.1. Company Overview 14.16.2. Product Portfolio 14.16.3. SWOT Analysis 14.16.4. Financial Overview 14.16.5. Strategic Overview 14.17. InnoMed Technologies 14.17.1. Company Overview 14.17.2. Product Portfolio 14.17.3. SWOT Analysis 14.17.4. Financial Overview 14.17.5. Strategic Overview 14.18. Hoffrichter Gmbh 14.18.1. Company Overview 14.18.2. Product Portfolio 14.18.3. SWOT Analysis 14.18.4. Financial Overview 14.18.5. Strategic Overview 14.19. Intersurgical 14.19.1. Company Overview 14.19.2. Product Portfolio 14.19.3. SWOT Analysis 14.19.4. Financial Overview 14.19.5. Strategic Overview 14.20. Medtronic 14.20.1. Company Overview 14.20.2. Product Portfolio 14.20.3. SWOT Analysis 14.20.4. Financial Overview 14.20.5. Strategic Overview 14.21. Invacare 14.21.1. Company Overview 14.21.2. Product Portfolio 14.21.3. SWOT Analysis 14.21.4. Financial Overview 14.21.5. Strategic Overview 14.22. Pahsco 14.22.1. Company Overview 14.22.2. Product Portfolio 14.22.3. SWOT Analysis 14.22.4. Financial Overview 14.22.5. Strategic Overview 14.23. Pneumocare 14.23.1. Company Overview 14.23.2. Product Portfolio 14.23.3. SWOT Analysis 14.23.4. Financial Overview 14.23.5. Strategic Overview 14.24. Penlon 14.24.1. Company Overview 14.24.2. Product Portfolio 14.24.3. SWOT Analysis 14.24.4. Financial Overview 14.24.5. Strategic Overview 14.25. Pulmodyne 14.25.1. Company Overview 14.25.2. Product Portfolio 14.25.3. SWOT Analysis 14.25.4. Financial Overview 14.25.5. Strategic Overview 14.26. Smiths Medical 14.26.1. Company Overview 14.26.2. Product Portfolio 14.26.3. SWOT Analysis 14.26.4. Financial Overview 14.26.5. Strategic Overview 14.27. Sleepnet 14.27.1. Company Overview 14.27.2. Product Portfolio 14.27.3. SWOT Analysis 14.27.4. Financial Overview 14.27.5. Strategic Overview 14.28. Somnetics 14.28.1. Company Overview 14.28.2. Product Portfolio 14.28.3. SWOT Analysis 14.28.4. Financial Overview 14.28.5. Strategic Overview 14.29. Sturdy Industrial 14.29.1. Company Overview 14.29.2. Product Portfolio 14.29.3. SWOT Analysis 14.29.4. Financial Overview 14.29.5. Strategic Overview 14.30. Weinmann Gerate fur Medizin. 14.30.1. Company Overview 14.30.2. Product Portfolio 14.30.3. SWOT Analysis 14.30.4. Financial Overview 14.30.5. Strategic Overview 15. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics